Back
MicroStrategy 10K Form
Sell
45
MSTR
MicroStrategy
Last Price:
328.31
Seasonality Move:
26.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-07-28 | 10Q | MSTR/MicroStrategy Quarterly |
2020-04-28 | 10Q | MSTR/MicroStrategy Quarterly |
2020-02-14 | 10K | MSTR/MicroStrategy Annual |
2019-10-29 | 10Q | MSTR/MicroStrategy Quarterly |
2019-07-30 | 10Q | MSTR/MicroStrategy Quarterly |
2019-04-30 | 10Q | MSTR/MicroStrategy Quarterly |
Receive MSTR News And Ratings
See the #1 stock for the next 7 days that we like better than MSTR
MSTR Financial Statistics
Sales & Book Value
Annual Sales: | $499.26M |
---|---|
Cash Flow: | $-366.11M |
Price / Cash Flow: | 0 |
Annual Sales: | $58.16 |
Price / Book: | 5.64 |
Profitability
EPS (TTM): | 8.99000 |
---|---|
Net Income (TTM): | $206.69M |
Gross Margin: | $396.28M |
Return on Equity: | 210.11% |
Return on Assets: | 7.43% |
MicroStrategy Earnings Forecast
Key MicroStrategy Financial Ratios
- The Gross Profit Margin over the past 26 years for MSTR is 79.37%.
- The Selling, General & Administrative Expenses for MSTR have been equal to 51.74% of Gross Profit Margin.
- The Research & Development expenses have been 25.52% of Revenue.
- The Interest Expense is -3.62% of Operating Income.
- The Net Earning history of MSTR is -294.40% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 11 years.
MicroStrategy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software - Application |
Sector: | Technology |
Current Symbol: | MSTR |
CUSIP: | 594972 |
Website: | microstrategy.com |
Debt
Debt-to-Equity Ratio: | 2.66 |
---|---|
Current Ratio: | 0.77 |
Quick Ratio: | 0.69 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 111.53 |
MSTR Technical Analysis vs Fundamental Analysis
Sell
45
MicroStrategy (MSTR)
is a Sell
Is MicroStrategy a Buy or a Sell?
-
MicroStrategy stock is rated a Sell
The current MicroStrategy [MSTR] share price is $327.89. The Score for MSTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.